Synergistic Glaucoma Treatment System using AI, IoT, and Blockchain

A novel system integrating visible and infrared ultrashort laser pulses with AI, IoT, and blockchain technologies to enhance glaucoma treatment outcomes and patient care.

The original patent disclosed methods for treating glaucoma using visible and infrared ultrashort laser pulses. However, these methods lacked the precision and personalization enabled by modern technologies. The new inventive concept addresses these limitations by incorporating AI-driven analysis, IoT-enabled real-time monitoring, and blockchain-based data storage to create a more effective and efficient glaucoma treatment system.

The Synergistic Glaucoma Treatment System consists of a laser device emitting visible and infrared ultrashort laser pulses, a fiberoptic delivery system, an AI module analyzing OCT images to guide the fiberoptic delivery system, IoT-enabled sensors for real-time monitoring, and a blockchain-based data storage system for tracking treatment outcomes and patient data. The AI module enables precise targeting of outflow obstructing tissues, while the IoT-enabled sensors provide real-time feedback for treatment optimization. The blockchain-based data storage system ensures secure and transparent tracking of patient data and treatment outcomes.

The new inventive concept introduces the novel combination of AI-driven analysis, IoT-enabled real-time monitoring, and blockchain-based data storage with visible and infrared ultrashort laser pulses, providing a significant improvement over the original patent's methods. The inventive step lies in the synergistic integration of these technologies to create a more effective, efficient, and personalized glaucoma treatment system.

Alternative embodiments of the Synergistic Glaucoma Treatment System could include the use of different AI algorithms, various IoT-enabled sensor configurations, or alternative blockchain-based data storage systems. Additionally, the system could be adapted for use in other ophthalmic treatments or integrated with other medical technologies.

The Synergistic Glaucoma Treatment System has significant commercial potential in the ophthalmic industry, particularly in the areas of glaucoma treatment and patient care. The system's ability to provide personalized, real-time treatment optimization and secure data tracking makes it an attractive solution for healthcare providers and patients alike.